Status:
RECRUITING
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
Lead Sponsor:
Hopital Foch
Conditions:
Lung Transplant Rejection
Lung Transplant Failure
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
Transplant results vary considerably from one organ to another. Lung transplantation has poorer long-term outcomes than other solid organ transplants, with a current median post-transplant survival of...
Eligibility Criteria
Inclusion
- Men or women over 15 years of age
- Suffering from a lung condition requiring a transplant planned at Foch Hospital or being followed up at Foch Hospital following a lung transplant
- Have signed the informed consent form and for patients aged 15 to 18 years that the person(s) exercising parental authority has/have signed the informed consent.
- Be affiliated with a Health Insurance plan.
Exclusion
- Pregnant, parturient and/or lactating woman
- Hemoglobin level less than or equal to 8g/dl
- Persons of full age who are subject to a legal protection measure or who are unable to express their consent
- Persons under the protection of justice
- Not being able to follow the study requirements for geographical, social or psychological reasons
- Patient refusal.
Key Trial Info
Start Date :
March 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2037
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04837339
Start Date
March 17 2022
End Date
March 1 2037
Last Update
August 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Roux
Suresnes, France